Very excited to be invited to give a talk on EBV and myeloid derived suppressor cells at ASH in San Diego in December. The scientific workshop is entitled ‘Viruses in Hematology: emerging challenges and therapeutic vulnerabilities’

Fab lineup of speakers for #lymphoma #CLL congress highlights👇🙌

I am seeking a post doc (3 years) to work with me and my group Centre for Blood Research York Biomedical Research Institute University of York on the microenvironment in acute lymphoblastic leukaemia. Advert is live on U of York jobs ref 12484 Fabulous environment, great science.

Thanks Charlie Craddock CBE Fantastic second AIM meeting today - helpful for anyone thinking of getting into trials with lots of great discussion & opportunity to learn

Just out in Blood Journal – our study exploring the origin of late relapses in T-ALL. Here's a short thread with our unexpected results! ashpublications.org/blood/article-…

Haematology friends - Please contribute to this - we need it to help maintain and shape our workforce of the future

NIHR Academic Clinical Lecturer post in Brum out for advert 👇 🙌 edzz.fa.em3.oraclecloud.com/hcmUI/Candidat…

So important to remember infection is leading cause if non-relapse mortality post CAR. Real need to standardise approach to prophylaxis in evidence based way. #lymsm Hartley Taylor

Come join us at UCLH, Great opportunity to work at one of the biggest haematology centres in the UK, working with some of the nicest people in trials Rakesh Popat Jen O & William Townsend

Malaria is a major cause of illness worldwide. In a phase 2 trial in Mali, one subcutaneous dose of L9LS, a monoclonal antibody targeting Plasmodium falciparum, reduced the incidence of clinical malaria among children. Full Mali Malaria mAb trial results: nej.md/3Ug6MTr

Really pleased to see this work has been published in Leukemia Journal Another evidence to support PD-1 plays a part on NK cell function. Thanks for the hard work and support from Mustafa F Helen Parry 💙 Dr francesca kinsella Shankara Paneesha nature.com/articles/s4137…

So important ❤️ Margaret O'Hara

Thanks to Graham McIlroy & Sridhar Chaganti for a great discussion on key aspects of the guideline. And to the talented writing group for all the work behind the manuscript pubmed.ncbi.nlm.nih.gov/38247115/ Kate Cwynarski Andrew Davies Andrea Kuhnl Toby Eyre Sally Barrington Pam McKay et al

📢 We're delighted to announce the launch of our new Early Career Advancement Fellowships! Up to £350,000 available to support researchers with the potential to become the next generation of blood cancer research leaders. Full details on our website - bloodcancer.org.uk/research/fundi…

📣 Our Early Career Advancement Fellowships are officially open for applications! 📣 These awards will support the brightest and best early career blood cancer researchers as they begin their journey to independence. Full details on our website bloodcancer.org.uk/research/fundi…